Rituximab and ABVD for Hodgkin's Patients

NCT00504504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Rituximab
DRUG: Adriamycin
DRUG: Bleomycin
DRUG: Vinblastine
DRUG: Dacarbazine (DTIC)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]